> what does that have to do with this regulatory proposal?
Article's subtitle is: The agency’s proposed new rule would allow it to ignore the best available science
The scenario is not so hypothetical. The circumstances and particulars change, but this situation describes a lot of medical and environmental research.
Should the EPA take the researcher's word? Maybe not. But there's a lot of workable middle ground in-between "blind trust" and "anyone with access to a library computer and a stats textbook can figure out participant 494 -- who math tells us can only possibly be Johnny D. of Smallsville, VA -- has testicular cancer".
And the situation is even more difficult than this because de-anonymization is an active area of research with some surprisingly powerful results published in recent years; i.e., it is highly non-trivial to determine if a dataset is de-anonymizable. And the answer always depends on what data about a person's identity is publicly available, which especially in the age of annual massive data leaks change from year to year. So even if researchers don't think it's possible to de-anonymize study participants using today's mathematical tools and today's public datasets, they'll often choose to keep the dataset private just in case.
There are thousands of old studies for which the data is unavailable, incomplete, was lost, etc. Are you going to pay for all of them to be reproduced? Are you ready to give up penicillin? Surgeons washing their hands between operations? The links between tobacco and cancer? Every single medical advancement (Because patient confidentiality precludes the release of raw data that goes into medical studies)?
I'm all for reproducibility, but this has enormous consequences.